Vedolizumab-5055: Long Term Outcomes of Drug Program for Biological Treatment in Adult Patients With Ulcerative Colitis in Poland (MAZUREK Study) First published 28/01/2020 Last updated 03/12/2024 EU PAS number:EUPAS32684 Study Finalised